Image Credit :https://www.psychiatryadvisor.com/home/bipolar-disorder-advisor/presence-of-psychosis-in-bipolar-depression-not-a-factor-in-treatment-outcomes/
Schizophrenia is associated with risk factors for poor outcomes with SARS-CoV-2/coronavirus disease 2019 (COVID-19) infection, including diabetes, hypertension, and chronic obstructive pulmonary disease (COPD). A recent study found that schizophrenia was associated with an increased risk of severe COVID-19 infection. Whether health outcomes and care differ between patients with COVID-19 with (versus without) comorbid schizophrenia remains unclear. Fond and colleagues2 compared in-hospital mortality and intensive care unit (ICU) admissions between patients with schizophrenia and those without a diagnosis of severe mental illness in a French population-based cohort study.
People with severe mental illness (SMI) are a vulnerable population. In the context of COVID-19, there is reason to suspect they may be at increased risk of contracting SARS-CoV-2 and have worse outcomes following infection, however we found no existing data that quantified these risks. Public health measures associated with COVID-19, including quarantine of suspected cases and lockdowns may negatively affect the mental health status of people with SMI, through change of environment, disruption of services, increased stress and isolation. Existing research points to greater psychological distress during the pandemic for people with SMI, rather than demonstrating this distress is due to the pandemic. The authors concluded that this is the largest series of patients with schizophrenia and COVID-19 to date. They found evidence for the existence of disparities in health and health care between patients with versus without schizophrenia, including increased in-hospital mortality and decreased ICU admission. Study limitations include the absence of data on the time between onset of infection and hospitalization, psychotropic medication, and the use of anti-COVID-19 treatments. Nevertheless, findings suggest the importance of health care strategies before, during, and after hospitalization for reducing health disparities in this vulnerable population
Normally, younger patients with schizophrenia who smoke, are obese, and have COPD are at heightened risk for poor outcomes with COVID-19 infection and should be targeted for early intervention.
Schizophrenia is a mental illness that affects how the brain works. People with schizophrenia experience psychosis, which means they can have serious problems with thinking clearly, emotions, and knowing what is real and what is not (YourHealthinMind, 2020). It is also known as the extreme form of anxiety which is normally marked by stress, tension and exertion.
Research has proved that men and women gave a ratio of 50 percent to get Schizophrenia and are prone to it. This disease, as mentioned by American Psychological Association (APA), is not 100 percent recoverable rather only 1 person out of every 7 persons who are affected by Schizophrenia gets recovered thus the recovery rates are less than 20 percent of the overall ratio.
It is not possible to predict how schizophrenia will affect someone’s life, because the symptoms, severity and pattern of illness over time differ widely between people. The impact of the illness also depends on the treatment and support they get to recover and stay well. The risk of being unable to work or live independently is higher when schizophrenia remains untreated for a long time or when a person does not get support to continue friendships and normal activities. The mental and physical health problems caused by Schizophrenia are as follows;
Recovering from anxiety and schizophrenia in specific can be very challenging for the patient and for the people around him or her. Thus the best way to tackle this issue is to consult a Psychologist or an experienced mental health professional which will help people recover from this concern.
Serene Retreat is one of the leading Addiction and Mental Health Treatment provider based in Malaysia with its branches locally and abroad. For more information about our treatment programs you can reach us via Call/Whatsapp+60 14-687 2268 or visit our website www.sereneretreat.com.my.
Schizophrenia is a chronic brain disorder that affects about one percent of the population. When schizophrenia is active, symptoms can include delusions, hallucinations, trouble with thinking and concentration, and lack of motivation. However, when these symptoms are treated, most people with schizophrenia will greatly improve over time.
When the disease is active, it can be characterized by episodes in which the patient is unable to distinguish between real and unreal experiences. As with any illness, the severity, duration and frequency of symptoms can vary; however, in persons with schizophrenia, the incidence of severe psychotic symptoms often decreases during a patient’s lifetime. Not taking medications as prescribed, use of alcohol or illicit drugs, and stressful situations tend to increase symptoms. Symptoms fall into several categories:
Symptoms usually first appear in early adulthood. Men often experience symptoms in their early 20s and women often first show signs in their late 20s and early 30s. More subtle signs may be present earlier, including troubled relationships, poor school performance and reduced motivation. It is rarely diagnosed in children or adolescents.
Once the symptoms occur, the next step is to consult a mental health professional or mental health treatment center near you. In Malaysia, there are various mental health treatment centers; among them one of the best is “Serene Retreat Psychology Center” It is located in Kualaumpur Malaysia. You can reach us via Call/Whatsapp +60146872268 or visit our website www.sereneretreat.com.my.
Image Credit Designed by kjpargeter / Freepik